Biotech and Pharma need to get
Email Encryption into their DNA

Unique challenges and risk factors


In early 2018, senior executives at Sangamo Therapeutics had their corporate email unlawfully accessed. For almost 3 months, hackers had unfettered access to the biotech’s sensitive emails containing proprietary, confidential and other sensitive information about the company.


In our newest whitepaper, we delve into why the past decade has seen a significant rise in attacks like the one on Sangamo and what are the impacts.  We also look into the:


  • Impact and cost of these attacks on security and profitability
  • Challenges to maintaining email security
  • Effective solutions to ensuring email security in the future


Download our whitepaper to learn how you can stop hackers from attacking your company’s emails and start finding effective end-to-end encryption solutions to combat them.